Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
As outlined in the 2024 Medicare Program: HOPPS and ASC Payment Systems Final Rule, CMS has confirmed that new Category III CPT code 0816T for...
Valencia Technologies Corporation announced today that the Department of Health and Human Services, Centers for Medicare & Medicaid Services (CMS),...
Valencia Technologies Corporation announced today that the Centers for Medicare & Medicaid Services (CMS), Division of Outpatient Care issued a...
Valencia Technologies Corporation, a privately held company, today announced that it has completed the world's first commercial implantation of...
Valencia Technologies Corporation ("Valencia" or the "Company"), a privately held company, today announced it has retained PRIA Healthcare to assist...
Valencia Technologies, a privately held company, today announced the appointment of Alexandra Rogers, M.D. as Vice President of Procedural Training,...
Valencia Technologies Corporation, a privately held company, today announced that the U.S. Food and Drug Administration (FDA) has granted premarket...
Valencia Technologies, a privately held company, today announced the expansion of its leadership team with the appointments of Jerry Schloffman as...
Valencia Technologies Corporation ("Valencia"), a private medical device company, today announced the presentation of positive results from their...
Valencia Technologies Corporation ("Valencia"), a private medical device company, today announced the filing of its pre-market approval (PMA)...
Valencia Technologies Corporation ("Valencia"), a private medical device company, today announced 6-month interim efficacy data from its eCoin...
Valencia Technologies Corporation ("Valencia"), a private medical device company, today announced interim efficacy data from the eCoin Pivotal...
Last week, The Journal of Urology published the feasibility data of Valencia Technologies' ("Valencia") eCoin™ device indicated for treatment of...
Yesterday, the FDA approved the conduct of a pivotal clinical trial using a new technology to treat overactive bladder. The technology, developed and ...
Valencia Technologies Corporation ("Valencia"), a privately held medical device company, today announced that it will for the first time publicly...
Valencia Technologies Corporation ("Valencia"), a privately held medical device company, announces that it has gained U.S. Food and Drug...
Valencia Technologies Corporation ("Valencia") was selected as one of five recipients of the 2015 Patrick Soon-Shiong Innovation Awards on November...
Valencia Technologies Corporation ("Valencia"), a medical device company that has created a tiny and inexpensive neurostimulator, announces the...
Lors du congrès EuroPCR 2015 de Paris, France, Valencia Technologies Corporation (« Valencia ») va présenter pour la première fois ses données...
At EuroPCR 2015 in Paris, France, Valencia Technologies Corporation ("Valencia") will present for the first time its technology and clinical data to...
At its annual conference in Atlanta on March 31 and April 1, 2015, the Southeastern Medical Device Association ("SEMDA"), a nonprofit trade...
Cochlear Corporation Vice President of U.S. Sales Jerry Schloffman has decided to leave Cochlear to join Valencia Technologies...
Valencia Technologies Corporation ("Valencia") implanted its 48th patient with its radically small device for the treatment of high blood pressure on ...
Valencia Technologies Corporation ("Valencia") launched a crowdfunding campaign on November 3, 2014 on its website, sharing with the public its...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.